Mandate

Vinge advised Creades on its investment in Apotea

April 28, 2017

Creades AB (publ) (Nasdaq Stockholm) has purchased 4.9 per cent of the shares in Apolea Holding AB, which is the parent company (96.5%) of the Internet pharmacy Apotea AB.

The investment by Creades amounts to a total of SEK 120.5 million.
 
Vinges team consisted of Erik Sjöman and Jesper Ottergren.
 

Related

Vinge advises Sveafastigheter on the establishment of its EMTN programme and issuance of EUR 300 million bonds

Vinge has advised Sveafastigheter AB (publ) as Swedish legal counsel on the establishment of a euro medium-term note programme (the “EMTN programme”) with a framework of EUR 2 billion and the issuance of senior unsecured bonds totalling EUR 300 million under the EMTN programme.
January 23, 2026

Vinge advises EQT AB on its combination with Coller Capital

Vinge advises EQT AB on its acquisition Coller Capital, a global secondaries firm with nearly USD 50 billion in total assets under management across institutional, private wealth and insurance-related capital.
January 22, 2026

Vinge advises Nordic Re-Finance AB on a Swedish railway financing

Vinge has acted as Swedish legal counsel to Nordic Re-Finance AB, a leading lessor of locomotives for rail freight traffic in Scandinavia, in connection with the execution of a EUR 250m debt package fully underwritten by Natixis CIB.
January 21, 2026